Adolore
's headquarters is in Delray Beach, Florida. Roy Clifford Levitt is the CEO of Adolore. Adolore has raised a total of $1.3M in funding. Adolore has 1 followers on Owler. Adolore has an estimated revenue of <$1M and an estimate of less <10 employees.Adolore
's headquarters is in Delray Beach, Florida. Roy Clifford Levitt is the CEO of Adolore. Adolore has raised a total of $1.3M in funding. Adolore has 1 followers on Owler. Adolore has an estimated revenue of <$1M and an estimate of less <10 employees.
News
Jan 16, 2026
Pharmabiz
Adolore: US FDA grants Orphan Drug Designation to Adolore BioTherapeutics' Kv7activating rdHSVCA8 therapy to treat erythromelalgia
Aug 12, 2025
FinanzNachrichten
Adolore: Adolore Biotherapeutics, Inc.: Dr. Roy Levitt, Executive Chairman of Adolore BioTherapeutics, Presented at the Next Generation Gene Therapy Vectors Summit
Jun 15, 2025
FinanzNachrichten
Adolore: Adolore Biotherapeutics, Inc.: Adolore BioTherapeutics Announces Publication Demonstrating Biosafety and Efficacy of Kv7 Activating rdHSV-CA8* Analgesic Gene Therapy for Chronic Pain via the Intra-Articular Route in Mice
Apr 23, 2025
FinanzNachrichten
Adolore: Adolore Biotherapeutics, Inc.: Adolore BioTherapeutics to Present at Festival of Biologics USA 2025
Feb 04, 2025
FinanzNachrichten
Adolore: Adolore Biotherapeutics, Inc.: Adolore BioTherapeutics to Present CA8* Neuromodulating Gene Therapy at the 2025 NANS Annual Meeting
Oct 02, 2024
FinanzNachrichten
Adolore: Adolore Biotherapeutics, Inc.: Adolore BioTherapeutics to Present at 18th Annual Pain Therapeutics Summit
Sep 05, 2024
StreetInsider
Press Release: Adolore : Adolore BioTherapeutics Announces Issuance of First Japanese Patent Covering CA8* Long-Acting Local Analgesic Therapies to Treat Chronic Pain
Jun 10, 2024
FinanzNachrichten
Adolore: Adolore Biotherapeutics, Inc.: Adolore BioTherapeutics to Present at the Virtual Investor Pitch Conference
May 21, 2024
FinanzNachrichten
Adolore: Adolore Biotherapeutics, Inc.: Adolore BioTherapeutics Outlines Strategy for its Next Generation, Disease-Modifying, Non-Opioid Analgesic Gene Therapies for the Treatment of Chronic Pain
May 16, 2024
FinanzNachrichten
Adolore: Adolore Biotherapeutics, Inc.: Adolore BioTherapeutics Announces Publication Demonstrating Carbonic Anhydrase-8 Gene Therapy Decreased Pain-Sensing Neuronal Excitability by Activating Kv7 Voltage-Gated Potassium Channels